Abstract
Japanese encephalitis virus (JEV) causes severe viral encephalitis in humans and some other mammalian animals. Highly efficient culture of the virus is critical for antigen preparation, vaccine production and other basic researches. We have investigated the influence of a number of variables such as the strain virulence, the state of the host cells, medium composition, infection method and others on the proliferation of distinct JEV strains in BHK-21 cells. The results showed that two distinct strategies are needed for the propagation of virulent or attenuated JEV strains. The most critical variables were the method of infection, and especially the density of the host cell. Our studies indicate the general approaches to the in vitro culture of other JEV strains using BHK-21 cell line.
References
Gajanana A, Rajendran R, Samuel PP. Japanese encephalitis in South Arcot district, Tamil Nadu, India: a three-year longitudinal study of vector abundance and infection frequency. J Med Entomol. 1997;34:651–9.
Igarashi A. Isolation of a Singh’s Aedes albopictus cell clone sensitive to Dengue and Chikungunya viruses. J Gen Virol. 1978;40:531–44.
Konno J, Endo K, Agatsuma H, Ishida N. Cyclic outbreaks of Japanese encephalitis among pigs and humans. Am J Epidemiol. 1966;84:292–300.
Ohrr H, Tandan JB, Sohn YM, Shin SH, Pradhan DP, Halstead SB. Effect of single dose of SA 14-14-2 vaccine 1 year after immunisation in Nepalese children with Japanese encephalitis: a case-control study. Lancet. 2005;366:1375–8.
Peiris JS, Amerasinghe FP, Amerasinghe PH, Ratnayake CB, Karunaratne SH, Tsai TF. Japanese encephalitis in Sri Lanka: the study of an epidemic: vector incrimination, porcine infection and human disease. Trans R Soc Trop Med Hyg. 1992;86:307–13.
Pirtle EC. Variation in the modal chromosome number of two PK-15 porcine kidney cell lines. Am J Vet Res. 1966;27:747–9.
Reed LJ, Muench H. A simple method for estimating fifty percent endpoints. Am J Hyg. 1938;27:493–7.
Sohn YM, Park MS, Rho HO, Chandler LJ, Shope RE, Tsai TF. Primary and booster immune responses to SA14-14-2 Japanese encephalitis vaccine in Korean infants. Vaccine. 1999;17:2259–64.
Stoker M, Macpherson I. Syrian Hamster fibroblast cell line BHK-21 and its derivatives. Nature. 1964;203:1355–7.
Van den Hurk AF, Ritchie SA, Mackenzie JS. Ecology and geographical expansion of Japanese encephalitis virus. Annu Rev Entomol. 2009;54:17–35.
Wang HY, Takasaki Y, Fu SH, Sun XH, Zhang HL, Wang ZX, Hao ZY, Zhang JK, Tang Q, Kotaki A, Tajima S, Liang XF, Yang WZ, Kurane I, Liang GD. Molecular epidemiological analysis of Japanese encephalitis virus in China. J Gen Virol. 2007;88:885–94.
**n YY, Ming ZG, Peng GY, Jian A, Min LH. Safety of a live-attenuated Japanese encephalitis virus vaccine (SA14-14-2) for children. Am J Trop Med Hyg. 1988;39:214–7.
Yasumura Y, Kawakita M. The research for the SV40 by means of tissue culture technique. Nippon Rinsho. 1963;21:1201–19.
Acknowledgments
This work was supported by the Special Fund for Agro-scientific Research in the Public Interest (Grant No. 201203082-5). The authors also gratefully acknowledge the critical review by Prof. Norman A. Gregson (ION, UCL, London, UK).
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Teng, M., Luo, J., **ng, GX. et al. Main Factors Influencing the Efficient Propagation of Virulent or Attenuated Strains of Japanese encephalitis virus in BHK-21 Cells. Indian J. Virol. 23, 344–348 (2012). https://doi.org/10.1007/s13337-012-0094-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13337-012-0094-z